Q99683 (M3K5_HUMAN) Homo sapiens (Human)

Mitogen-activated protein kinase kinase kinase 5 UniProtKBInterProSTRINGInteractive Modelling

1374 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

27 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of 14-3-3 zeta in complex with ASK1 14-3-3 binding motif Heteromer
P63104;
964-970
100
Cryo-EM structure of C-terminally truncated Apoptosis signal-regulating kinase 1 (ASK1)homo-2-mer95-940
100.0
ASK1 kinase domain in complex with GS-4997homo-2-mer667-939
100.0NJV;ACT;
ASK1 kinase domain complex with inhibitorhomo-2-mer670-940
100.0KK7;
Structure of mitogen-activated protein kinase kinase kinase 5homo-2-mer670-940
100.0STU;
ASK1 kinase domain complex with inhibitorhomo-2-mer670-939
100.0KK8;
ASK1 kinase domain complex with inhibitorhomo-2-mer670-939
100.0S0L;
Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibit…homo-2-mer671-939
100.0IM6;
ASK1 kinase domain in complex with Compound 11homo-2-mer671-939
99.61NKJ;MG;
Structure of the ASK1 central regulatory regionmonomer272-655
100.0
Crystal Structures of Ask1-inhibitor Complexesmonomer670-940
99.61BH9;GOL;
Crystal Structures of Ask1-inhibitor Complexesmonomer670-940
99.61GOL;IE6;
Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failuremonomer670-940
100.08GY;
Crystal Structures of Ask1-inhibitor Complexesmonomer670-940
99.61IE4;GOL;
Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 6)monomer670-940
1009E1;DMS;
Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)monomer670-940
1009E4;
Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failuremonomer670-940
100.08GS;
Structure of ASK1 bound to BIO-1772961monomer671-940
99.62DMS;RFG;
Ask1 bound to compound 3monomer671-940
99.62DMS;EDO;RFG;
Crystal Structures of Ask1-inhibitor Complexesmonomer670-939
99.61IEO;GOL;ACT;
Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and …monomer671-940
100.0V3S;
Crystal Structures of Ask1-inhibitor Complexesmonomer670-939
99.61ACT;IE8;
Crystal Structures of Ask1-inhibitor Complexesmonomer671-939
99.61STU;GOL;
Ask1 bound to compound 28monomer671-939
99.61A1AWT;
Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization str…monomer671-939
100.08V7;
Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failuremonomer671-939
100.0SO4;8GV;
Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization str…monomer671-939
100.08V4;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8qgy.1.Ahomo-2-mer0.7095-940
99.66
8jfk.1.Jmonomer0.55679-1024
22.49

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28jfk.1.Jmonomer0.541-270
22.90